These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2835529)
1. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer]. Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529 [No Abstract] [Full Text] [Related]
2. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Schneider J; Philipp M; Salewski L; Velcovsky HG Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474 [TBL] [Abstract][Full Text] [Related]
3. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]. Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108 [TBL] [Abstract][Full Text] [Related]
4. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544 [TBL] [Abstract][Full Text] [Related]
5. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study]. Emin Erbaycu A; Gunduz A; Batum O; Zeren Ucar Z; Tuksavul F; Zeki Guclu S Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457 [TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase (NSE) serum level in non small cell lung cancer--can it be an indicator of tumour chemosensitivity? Zych J; Sakowicz A; Radzikowska E; Załeska J; Rowińska-Zakrzewska E Rocz Akad Med Bialymst; 1997; 42 Suppl 1():173-8. PubMed ID: 9337535 [TBL] [Abstract][Full Text] [Related]
7. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer. Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer. Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383 [TBL] [Abstract][Full Text] [Related]
9. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC. Ebert W; Muley T; Trainer C; Dienemann H; Drings P Anticancer Res; 2002; 22(2B):1083-9. PubMed ID: 12168905 [TBL] [Abstract][Full Text] [Related]
10. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels]. Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919 [TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer]. Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525 [No Abstract] [Full Text] [Related]
12. [Evaluation of tumor markers in the management of small cell lung cancer]. Ariyoshi Y Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):959-65. PubMed ID: 2839115 [TBL] [Abstract][Full Text] [Related]
13. [Serum neuron-specific enolase (NSE) in patients with primary lung cancer]. Oribe H; Kato R; Noguchi S; Kai T Rinsho Byori; 1988 Apr; 36(4):464-8. PubMed ID: 2841516 [No Abstract] [Full Text] [Related]
14. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer. Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404 [TBL] [Abstract][Full Text] [Related]
15. [Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma]. Gasser RW; Herold M; Müller-Holzner E; Müller LC; Salzer GM; Huber H Dtsch Med Wochenschr; 1988 Nov; 113(44):1708-13. PubMed ID: 2846253 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the response to chemotherapy in patients affected with small cell lung cancer using discriminant analysis: a preliminary report. Paone G; De Angelis G; Pallotta G; Giannarelli D; Bisetti A; Pigorini F; Ameglio F Q J Nucl Med; 1995 Jun; 39(2):140-3. PubMed ID: 8574809 [TBL] [Abstract][Full Text] [Related]
17. Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer. Scagliotti GV; Piani M; Gatti E; Gozzelino F; Albera C; Pozzi E Eur Respir J; 1989 Sep; 2(8):746-50. PubMed ID: 2553476 [TBL] [Abstract][Full Text] [Related]
18. [Neuron-specific enolase in bronchial anaplastic small-cell cancer: a clinical case and review of the literature]. Alamé T; Themelin D; Vincke G; Longeval E; Delmez JP Rev Med Brux; 1988 Apr; 9(3):155-7. PubMed ID: 2840726 [No Abstract] [Full Text] [Related]
19. [Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer]. Zych J; Szturmowicz M; Sakowicz A; Słodkowska J; Załeska M; Radzikowska E; Załeska J; Jodkiewicz Z; Rowińska-Zakrzewska E Pneumonol Alergol Pol; 2002; 70(5-6):278-83. PubMed ID: 12518626 [TBL] [Abstract][Full Text] [Related]